Better Buy: Calumet Specialty Products Partners LP vs. Ashland Global Holdings
At the start of 2016, specialty chemical manufacturer Calumet Specialty Products Partners LP (NASDAQ: CLMT) was a toxic stock. It had a balance sheet overloaded with debt, sky-high expenses, and as an MLP seemed to lack the financial flexibility needed to turn itself around. On the other hand, Ashland Global Holdings (NYSE: ASH) owned a profitable and diversified business that presented investors with promising upside.
It's now a little over 18 months later, and a lot has changed. Ashland still owns profitable operations, although margins have soured since completing the spinoff of Valvoline (NYSE: VVV) in May. Meanwhile, Calumet Specialty Products Partners has soared thanks to solid execution against a turnaround strategy that many thought would be very difficult to pull off.
How do these changes affect the medium- and long-term prospects of each company, and which stock is the better buy?
Source: Fool.com
Calumet Speciality Products Stock
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 16 € there is potential for a 724.74% increase which would mean more than doubling the current price of 1.94 € for Calumet Speciality Products.
